Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs
about
Solution NMR structure of the N-terminal domain of the human DEK proteinThe human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7Melanoma proliferation and chemoresistance controlled by the DEK oncogeneDEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigenApoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.The DEK nuclear autoantigen is a secreted chemotactic factorSystemic chemotherapy is modulated by platelet-activating factor-receptor agonists.Solution NMR structure of the C-terminal domain of the human protein DEK.Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells.DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stressDEK proto-oncogene expression interferes with the normal epithelial differentiation program.Chemotherapy Resistance Mechanisms in Advanced Skin Cancer.Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer.Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion.
P2860
Q54905337-94895C3A-F49B-47B7-9A34-ED95E587904BQ54905338-24C9F37C-8BF3-4920-99ED-2B495581DF26Q54905339-C8A31BCA-69B3-46F7-A2D9-493449AD3ACBQ54905340-E3D958A8-E966-41A5-96B3-ABAC3A09B2A6Q54905341-A57CC239-ED3F-46CC-8219-783DD9EB5110Q54905343-0C0D3560-C1D3-471D-B6F3-69AC1303F854Q54905345-7417614E-2593-4222-B059-DB217770096CQ54905346-C601EC79-7FCF-4C5F-B9A5-31509AEB8394
P1343
Q27649727-FCD86E9A-AF02-487B-B91B-F0624C9FF48FQ34124022-549CD195-E7A8-4290-8C02-9A518B5087B4Q34997265-2C969F64-82DF-4357-8510-F6EA589BA5DCQ35051109-94C5D816-49C2-4956-899C-61D14B33BAD0Q35131718-C70C1897-02F6-4DD4-99E6-B0FDD4033A20Q35221391-E5BA94A2-965C-4A99-924A-AFC4ED01C10CQ35438088-F0619E6D-9C3D-4A9A-AB28-CC2EC19F97AAQ36519194-67DE4323-3F21-47F5-B2BC-A68121205514Q36695280-7461F094-6CC4-4644-A62A-6F08F6D30A85Q36710870-F19105D4-BB8C-4CB2-9EC5-A01347E56647Q37073767-2AED697B-F188-45C2-874A-68C9877219EEQ37736532-FF0DD48B-3B6F-4771-AE1B-9708441C5204Q40212302-7A3D1737-5739-4530-B41F-1F1F5C7541A1Q55345164-ECD85CBE-79E0-40DC-B7BA-19BDBB4F00BC
P2860
Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Identification of differential ...... o various antineoplastic drugs
@ast
Identification of differential ...... o various antineoplastic drugs
@en
Identification of differential ...... o various antineoplastic drugs
@nl
type
label
Identification of differential ...... o various antineoplastic drugs
@ast
Identification of differential ...... o various antineoplastic drugs
@en
Identification of differential ...... o various antineoplastic drugs
@nl
prefLabel
Identification of differential ...... o various antineoplastic drugs
@ast
Identification of differential ...... o various antineoplastic drugs
@en
Identification of differential ...... o various antineoplastic drugs
@nl
P2093
P4510
P1476
Identification of differential ...... o various antineoplastic drugs
@en
P2093
P304
P356
10.1002/1097-0215(20001115)88:4<535::AID-IJC4>3.3.CO;2-M
P407
P577
2000-11-15T00:00:00Z